Cirqle Biomedical Contraception ApS — Credit Rating and Financial Key Figures
CVR number: 39865769
Ole Maaløes Vej 3, 2200 København N
fm@cirqle.bio
tel: 26831750
Income statement (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | -1 094.00 | -4 133.00 | -5 696.00 | 62 142.00 | -12 848.48 |
| Employee benefit expenses | -1 218.00 | -2 182.00 | -2 803.00 | -3 399.00 | -8 379.30 |
| Total depreciation | -8.36 | ||||
| EBIT | -2 312.00 | -6 315.00 | -8 499.00 | 58 743.00 | -21 236.14 |
| Other financial income | 3.00 | 5.00 | 65.00 | 1 040.81 | |
| Other financial expenses | - 200.00 | - 403.00 | - 287.00 | - 440.00 | - 592.68 |
| Pre-tax profit | -2 512.00 | -6 715.00 | -8 781.00 | 58 368.00 | -20 788.01 |
| Income taxes | 417.00 | 1 157.00 | 1 573.00 | -10 686.00 | 4 803.19 |
| Net earnings | -2 095.00 | -5 558.00 | -7 208.00 | 47 682.00 | -15 984.82 |
Assets (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Machinery and equipment | 51.80 | ||||
| Tangible assets total | 51.80 | ||||
| Other receivables | 49.00 | 110.00 | 479.78 | ||
| Investments total | 49.00 | 110.00 | 479.78 | ||
| Long term receivables total | |||||
| Inventories total | |||||
| Current amounts owed by group member comp. | 463.00 | 66.00 | 12 204.00 | ||
| Current other receivables | 84.00 | 127.00 | 370.00 | 445.00 | 701.34 |
| Current deferred tax assets | 417.00 | 1 157.00 | 1 632.00 | 4 888.82 | |
| Short term receivables total | 501.00 | 1 747.00 | 2 068.00 | 12 649.00 | 5 590.16 |
| Cash and bank deposits | 5 978.00 | 9 037.00 | 1 512.00 | 57 460.00 | 39 813.99 |
| Cash and cash equivalents | 5 978.00 | 9 037.00 | 1 512.00 | 57 460.00 | 39 813.99 |
| Balance sheet total (assets) | 6 479.00 | 10 784.00 | 3 629.00 | 70 219.00 | 45 935.73 |
Equity and liabilities (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 1.00 | 40.00 | 40.00 | 44.00 | 44.17 |
| Retained earnings | 8 362.00 | 2 805.00 | 2 624.00 | 50 307.03 | |
| Profit of the financial year | -2 095.00 | -5 558.00 | -7 208.00 | 47 682.00 | -15 984.82 |
| Shareholders equity total | -2 094.00 | 2 844.00 | -4 363.00 | 50 350.00 | 34 366.38 |
| Non-current loans from credit institutions | 7 483.00 | ||||
| Non-current other liabilities | 40.00 | 7 000.00 | 7 129.00 | ||
| Non-current deferred tax liabilities | 7 477.00 | 8 068.89 | |||
| Non-current liabilities total | 7 523.00 | 7 000.00 | 7 129.00 | 7 477.00 | 8 068.89 |
| Current trade creditors | 917.00 | 600.00 | 587.00 | 1 204.00 | 2 369.66 |
| Current owed to group member | 184.05 | ||||
| Short-term deferred tax liabilities | 10 686.00 | ||||
| Other non-interest bearing current liabilities | 133.00 | 340.00 | 276.00 | 502.00 | 946.75 |
| Current liabilities total | 1 050.00 | 940.00 | 863.00 | 12 392.00 | 3 500.47 |
| Balance sheet total (liabilities) | 6 479.00 | 10 784.00 | 3 629.00 | 70 219.00 | 45 935.73 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.